Skip to content

The Effect of Respiratory Training on Exercise Tolerance in COPD

The Effect of Respiratory Training With Normocapnic Hyperpnea on Exercise Tolerance in COPD

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04201522
Acronym
ERTET
Enrollment
40
Registered
2019-12-17
Start date
2017-03-14
Completion date
2021-02-28
Last updated
2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Keywords

Respiratory training, COPD, Muscle oxygenation, Muscle fatigue, Oxygen kinetic, Exercise tolerance

Brief summary

Exercise intolerance is one of the key disabling factors in patients with chronic obstructive pulmonary disease (COPD). Although multifactorial, exercise intolerance involves physiological interactions between respiratory and locomotor muscles that may contribute to further reducing exercise tolerance in COPD. The respiratory muscle work during exercise is closely related to breathing and could induce respiratory muscle fatigue in patients with COPD. Respiratory muscle training is an intervention strategy that is sometimes proposed for some patients with COPD, especially whose with inspiratory muscle weakness. It was reported that inspiratory muscle training improves inspiratory muscle endurance and strength, dyspnea and exercise tolerance. There are two types of inspiratory muscle training, inspiratory muscle training against a resistive loading and normocapnic hyperpnoea. The advantage of normocapnic hyperpnoea compared to resistive training is the possibility to simulate the exercise ventilation level while maintaining stable the partial pressure of arterial carbon dioxide and end-tidal pressure of carbon dioxide and to solicit the inspiratory and expiratory muscles together, which could increase respiratory muscle tolerance and avoid their fatigue during whole-body exercise. Therefore, the aim of this project is to study the effect of normocapnic hyperpnoea training on exercise tolerance in patients with COPD. We hypothesize that greater improvement in cycling exercise tolerance will be observed following 6-weeks normocapnic hyperpnoea training compared to a sham intervention in patients with COPD.

Interventions

OTHERNormocapnic hyperpnoea intervention

Patients will perform for 6-weeks, 15 min twice daily, 5 days a week at 60% of the peak of minute ventilation, at home by means of a respiratory device (SpiroTiger, Idiag, Fehraltorf, CH).

OTHERSham intervention

Patients will perform for 6-weeks, 15 min twice daily, 5 days a week at rest's minute ventilation, at home by means of a respiratory device (SpiroTiger, Idiag, Fehraltorf, CH).

Sponsors

Oueslati, Ferid, PhD
CollaboratorUNKNOWN
Saey, Didier, M.D.
CollaboratorINDIV
Laval University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Patients will be randomized to training group or sham group.

Intervention model description

The study is a randomized, controlled, parallel-group trial.

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 40 years; * Chronic airflow obstruction : FEV1/FVC \< 0.7, FEV1 of 30 to 80% predicted, after bronchodilation;

Exclusion criteria

* Inability to perform a cycling exercise; * Diagnosed of one of more comorbidities that may limit exercise tolerance : cardiovascular, metabolic, endocrine, gastrointestinal, renal, neurological or rheumatologically disease; * Recent COPD exacerbation (\< 3 months); * Recent cancer; * A daily dose of Prednisone \> 10 mg; * Hypoxemia at rest or during exercise: PaO2 \< 60 mmHg or SpO2 ≤ 88%; * Body mass index \> 30 kg/m²; * Pregnancy; * Skinfold at intercostal or vastus lateralis muscle \> 1.5 cm.

Design outcomes

Primary

MeasureTime frameDescription
Change in exercise tolerance (time [seconds])Baseline (week 0), 7 weeksConstant workrate cycling exercise time at 75% of power peak.

Secondary

MeasureTime frameDescription
Minute ventilation responses (flow [L/min])Baseline (week 0), 7 weeksMinute ventilation during the constant workrate cycling exercise will be determined using a portable gas analysis system.
Change in respiratory muscle strength (pressure [cm H2O])Baseline (week 0), 7 weeksMaximal inspiratory and expiratory pressures will be assessed with a portable manometer before and at end the constant workrate cycling exercise.
Change in muscle oxygenation (from baseline [%])Baseline (week 0), 7 weeksDeoxyhemoglobin/myoglobin concentrations measured by near-infrared spectroscopy of intercostal and vastus lateralis muscle during the constant workrate cycling exercise
Change in cardiac output (flow [L/min])Baseline (week 0), 7 weeksArterial blood pressures and cardiac output will be non-invasively measured by a finger photoplethysmography device during the constant workrate cycling exercise
Isometric muscle strength (force [Kg])Baseline (week 0), 7 weeksMaximum voluntary isometric contraction with twitch tension induced by supramaximal magnetic stimulation of the femoral nerve will be realized before and 15 minutes after the constant workrate cycling exercise.

Countries

Canada

Contacts

Primary ContactFerid Oueslati, PhD
ferid.oueslati@criucpq.ulaval.ca+1 (418) 656-8711
Backup ContactDidier Saey, Pht, PhD
Didier.Saey@rea.ulaval.ca+1 (418) 656-8711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026